Larry Robbins portfolio, Q2 2026

Glenview Capital Management · 13F for the quarter ending Jun 30, 2026

For Q2 2026, Glenview Capital Management reported $5B across 42 US-listed positions, led by GPN (12.9%), CVS (10.0%) and THC (8.4%). Compared with its filing for Q1 2026, Larry Robbins opened 12 new positions, added to 14, reduced 15 and sold out of 11; 1 position did not change.

The largest purchase was a new position in A ($261.6M); the largest sale, a reduction of CVS ($348.8M).

This is the latest filing on file; the main portfolio page shows the same holdings against today's prices.

Reported value
$5B
Positions
42
In the top 10
64%
Filed
Aug 14
2026

Key facts

13F portfolio value
$5BQ2 2026
Positions
42
Largest holding
GPN 12.9%
New positions
12
Sold out
11
Filed
Aug 14, 2026

Holdings as of (Q2 2026), filed with the SEC on . Changes are measured against the filing for Mar 31, 2026. Every tracked investor's Q2 2026 13F.

Bought and sold in Q2 2026

Larry Robbins: buys and sells in Q2 2026
StockMoveSharesSizeOf portfolio
CVS Health CorpCVS▼ Reduced 41%−3.37M$348.8M6.97%
Agilent Technologies IncA▲ New+1.97M$261.6M5.23%
Advanced Micro Devices IncAMD▼ Reduced 54%−352.38K$204.7M4.09%
Thermo Fisher Scientific IncTMO▲ Added 150%+376.72K$188.9M3.77%
Danaher CorpDHR▲ Added 633%+989.7K$188.5M3.77%
Global PMTS IncGPN▲ Added 40%+2.55M$184.8M3.69%
Tenet Healthcare CorpTHC▲ Added 47%+710.81K$133M2.66%
Meta Platforms IncMETA▲ Added 191%+234.18K$131.9M2.63%
DXC Technology CoDXC▼ Sold out−8.9M$111.8M2.23%
Applied Materials IncAMAT▼ Reduced 67%−132.01K$95.4M1.91%
Zoominfo Technologies IncGTM▼ Sold out−15.91M$95.1M1.90%
Centene CorpCNC▼ Reduced 41%−1.33M$85.2M1.70%
Eli Lilly & CoLLY▲ New+57.77K$69.3M1.38%
Teva Pharmaceutical IndustriesTEVA▼ Reduced 24%−1.58M$53.5M1.07%
Amazon.com IncAMZN▲ Added 20%+212.42K$50.6M1.01%
MKS IncMKSI▲ New+98.53K$43.8M0.88%
Stmicroelectronics N VSTM▲ New+560.06K$41.9M0.84%
AbbVie IncABBV▲ New+148.91K$37.5M0.75%
Onto Innovation IncONTO▼ Reduced 31%−93.93K$35.5M0.71%
US Foods Holding CorpUSFD▼ Sold out−384.01K$35.4M0.71%
AstraZeneca PLCAZN▲ New+184.28K$34.9M0.70%
Zillow Group IncZ▼ Sold out−789.67K$32.7M0.65%
Humana IncHUM▼ Reduced 24%−80.68K$32M0.64%
Lithia Motors IncLAD▼ Sold out−127.61K$31.9M0.64%
Element Solutions IncESI▼ Reduced 39%−634.1K$30.3M0.60%
Genius Sports LtdGENI▲ Added 58%+4.93M$29.9M0.60%
National Vision Holdings IncEYE▲ Added 98%+1.54M$29.2M0.58%
Lionsgate Studios CorpLION▼ Sold out−2.78M$26.6M0.53%
Digitalocean Holdings IncDOCN▼ Reduced 66%−165.19K$25.9M0.52%
Elevance HealthELV▲ New+66.6K$25.8M0.51%
Uber Technologies IncUBER▲ Added 23%+337.73K$24.4M0.49%
Myriad Genetics IncMYGN▼ Sold out−5.41M$24.4M0.49%
Microchip Technology IncMCHP▲ New+265.58K$24.2M0.48%
The Cigna GroupCI▼ Reduced 17%−86.62K$23.9M0.48%
Dicks Sporting Goods IncDKS▲ Added 34%+102.16K$23.2M0.46%
Surgery Partners IncSGRY▼ Sold out−1.8M$21.5M0.43%
Akamai Technologies IncAKAM▼ Sold out−156.45K$18M0.36%
Intel CorpINTC▼ Sold out−399.51K$17.6M0.35%
Bruker CorpBRKR▲ New+252.17K$15.2M0.30%
Novartis AGNVS▲ New+86.91K$13.6M0.27%
Block IncXYZ▼ Reduced 12%−167.43K$12.7M0.25%
Viatris IncVTRS▲ Added 8.7%+790.17K$12.5M0.25%
Baker Hughes CoBKR▲ Added 63%+189.84K$10.5M0.21%
Biogen IncBIIB▼ Sold out−57.02K$10.5M0.21%
Bio-Techne CorpTECH▼ Reduced 69%−127.99K$9M0.18%
Cisco Systems IncCSCO▲ Added 22%+73.51K$8.6M0.17%
Boston Scientific CorpBSX▲ New+113.1K$4.8M0.10%
Six Flags Entertainment CorpFUN▼ Reduced 9.2%−205.33K$4.4M0.09%
Cardinal Health IncCAH▲ New+18.02K$4.3M0.09%
Primo Brands CorporationPRMB▼ Reduced 24%−126.08K$3.1M0.06%
United Airls Hldgs IncUAL▼ Reduced 0.4%−2.12K$288.8K0.01%
Bausch Plus Lomb CorpBLCO▲ Added 0.4%+7.65K$126.7K0.00%

Holdings at the quarter's end

Larry Robbins holdings, Q2 2026
#StockSectorShare of portfolioValueSharesReported priceHeldSince Q1 2026
1Global PMTS IncGPNFinancials12.9%$646.3M8.91M$72.569+ qtrs▲ Added 40%
2CVS Health CorpCVSHealth Care9.97%$499.1M4.82M$103.459+ qtrs▼ Reduced 41%
3Tenet Healthcare CorpTHCHealth Care8.36%$418.2M2.24M$187.089+ qtrs▲ Added 47%
4Thermo Fisher Scientific IncTMOHealth Care6.28%$314.5M627.24K$501.365 qtrs▲ Added 150%
5Amazon.com IncAMZNConsumer Discretionary6.05%$303.1M1.27M$238.349+ qtrs▲ Added 20%
6Agilent Technologies IncAHealth Care5.23%$261.6M1.97M$132.831 qtrNew
7Danaher CorpDHRHealth Care4.36%$218.3M1.15M$190.485 qtrs▲ Added 633%
8Meta Platforms IncMETA · CL ACommunication4.02%$201M356.84K$563.296 qtrs▲ Added 191%
9Advanced Micro Devices IncAMDTechnology3.46%$173.3M298.41K$580.913 qtrs▼ Reduced 54%
10Teva Pharmaceutical IndustriesTEVA · SPONSORED ADSHealth Care3.44%$172.1M5.08M$33.889+ qtrs▼ Reduced 24%
11Viatris IncVTRSHealth Care3.13%$156.9M9.88M$15.889+ qtrs▲ Added 8.7%
12Uber Technologies IncUBERIndustrials2.59%$129.4M1.79M$72.169+ qtrs▲ Added 23%
13Centene CorpCNCHealth Care2.42%$121.1M1.89M$64.194 qtrs▼ Reduced 41%
14Butterfly Network IncBFLY—2.41%$120.7M14.34M$8.429+ qtrsNo change
15The Cigna GroupCIHealth Care2.27%$113.6M412.22K$275.689+ qtrs▼ Reduced 17%
16Humana IncHUMHealth Care2.02%$101M254.22K$397.222 qtrs▼ Reduced 24%
17Block IncXYZ · CL ATechnology1.82%$91M1.2M$76.004 qtrs▼ Reduced 12%
18Dicks Sporting Goods IncDKSConsumer Discretionary1.82%$91M401.07K$226.815 qtrs▲ Added 34%
19Genius Sports LtdGENI · SHARES CL A—1.63%$81.8M13.5M$6.063 qtrs▲ Added 58%
20Onto Innovation IncONTOTechnology1.56%$77.9M205.79K$378.454 qtrs▼ Reduced 31%
21Eli Lilly & CoLLYHealth Care1.38%$69.3M57.77K$1,199.431 qtrNew
22United Airls Hldgs IncUALIndustrials1.34%$67.3M494.74K$135.996 qtrs▼ Reduced 0.4%
23National Vision Holdings IncEYE—1.18%$59M3.1M$19.015 qtrs▲ Added 98%
24Cisco Systems IncCSCOTechnology0.97%$48.5M413.33K$117.462 qtrs▲ Added 22%
25Element Solutions IncESIMaterials0.95%$47.5M994.58K$47.759+ qtrs▼ Reduced 39%
26Applied Materials IncAMATTechnology0.94%$47.1M65.2K$723.003 qtrs▼ Reduced 67%
27MKS IncMKSIIndustrials0.88%$43.8M98.53K$444.801 qtrNew
28Six Flags Entertainment CorpFUN—0.86%$43M2.02M$21.303 qtrs▼ Reduced 9.2%
29Stmicroelectronics N VSTM · NY REGISTRYTechnology0.84%$41.9M560.06K$74.891 qtrNew
30AbbVie IncABBVHealth Care0.75%$37.5M148.91K$251.641 qtrNew
31AstraZeneca PLCAZN · ORDHealth Care0.70%$34.9M184.28K$189.621 qtrNew
32Bausch Plus Lomb CorpBLCOHealth Care0.64%$31.8M1.92M$16.566 qtrs▲ Added 0.4%
33Baker Hughes CoBKR · CL AEnergy0.55%$27.4M493.52K$55.502 qtrs▲ Added 63%
34Elevance HealthELVHealth Care0.51%$25.8M66.6K$386.731 qtrNew
35Microchip Technology IncMCHPTechnology0.48%$24.2M265.58K$91.201 qtrNew
36Bruker CorpBRKRHealth Care0.30%$15.2M252.17K$60.181 qtrNew
37Novartis AGNVS · SPONSORED ADRHealth Care0.27%$13.6M86.91K$156.721 qtrNew
38Digitalocean Holdings IncDOCNTechnology0.27%$13.3M84.81K$157.033 qtrs▼ Reduced 66%
39Primo Brands CorporationPRMB · CLASS A COM SHSConsumer Staples0.20%$9.9M404.97K$24.442 qtrs▼ Reduced 24%
40Boston Scientific CorpBSXHealth Care0.10%$4.8M113.1K$42.681 qtrNew
41Cardinal Health IncCAHHealth Care0.09%$4.3M18.02K$237.561 qtrNew
42Bio-Techne CorpTECHHealth Care0.08%$4.1M58.32K$70.654 qtrs▼ Reduced 69%

By sector

Larry Robbins portfolio by sector, Q2 2026
SectorShare of portfolioValuePositions
Health Care52.3%$2.6B20
Financials12.9%$646.3M1
Technology10.3%$517.4M8
Consumer Discretionary7.87%$394.1M2
Industrials4.80%$240.5M3
Communication4.02%$201M1
Materials0.95%$47.5M1
Energy0.55%$27.4M1
Consumer Staples0.20%$9.9M1
No sector on file6.08%$304.4M4

Questions and answers

What did Larry Robbins own in Q2 2026?

Glenview Capital Management's 13F for Q2 2026 lists 42 positions worth $5B. The largest: GPN (12.9%), CVS (10.0%), THC (8.4%), TMO (6.3%), AMZN (6.1%).

What did Larry Robbins buy in Q2 2026?

The largest purchases, by the shares bought at the quarter-end price the filing implies: A (new, $261.6M), TMO (added, $188.9M), DHR (added, $188.5M), GPN (added, $184.8M), THC (added, $133M), META (added, $131.9M).

What did Larry Robbins sell in Q2 2026?

The largest sales: CVS (reduced, $348.8M), AMD (reduced, $204.7M), DXC (sold out, $111.8M), AMAT (reduced, $95.4M), GTM (sold out, $95.1M), CNC (reduced, $85.2M).

When was this filing made?

Glenview Capital Management filed its 13F for the quarter ending Jun 30, 2026 on Aug 14, 2026. A 13F is due within 45 days of the quarter's end, so the positions were already weeks old when it became public.

Learn

Cite this page

Funkfolio, “Larry Robbins portfolio, Q2 2026: Glenview Capital Management 13F holdings”, data as of 14 August 2026. https://funkfolio.com/gurus/larry-robbins/2026-q2

Underlying data: SEC EDGAR, Form 13F-HR of Glenview Capital Management (CIK 1138995) for the period ending Jun 30, 2026.

Source: SEC EDGAR, Form 13F-HR for Glenview Capital Management (CIK 1138995), period ending Jun 30, 2026, filed Aug 14, 2026. Changes compare share counts with the filing for Mar 31, 2026; a share split in between is allowed for where one is on record. “Reported price” is a position's reported value divided by its shares. The size of a buy or sell is the change in shares at that price; a position sold out is sized at its value in the previous filing, and “of portfolio” sets the size against the $5B reported for this quarter. “Held” counts consecutive quarterly filings up to this one, out of the 9 looked at from here back. Sectors are those of the ranked companies on this site as they stand today. 3 option positions in the filing are not shown. Not a live portfolio and not advice.